, Tracking Stock Market Picks
Enter Symbol:
Rating: A
Neutral $45
down 30.00 %

Agilent Technologies, Inc. (NYSE: A) downgraded to Neutral with price target $45 by UBS

Tuesday,  Mar 10, 2015  1:25 PM ET by Dave Ficere

UBS downgraded Agilent Technologies, Inc. (NYSE: A) to Neutral with price target $45. Previously UBS rated Buy with price target $65 Agilent Technologies, Inc.
(NYSE: A) on 01/10/2014, when the stock price was $58.84. Since then, Agilent Technologies, Inc.'s stock price has lost 30% as of 03/10/2015's recent price of $40.91.
If you would have followed the previous UBS's recommendation on A, you would have lost 30% of your investment in 424 days.

Agilent Technologies, Inc. is a measurement company providing bio-analytical and electronic measurement solutions to the communications, electronics, life sciences and chemical analysis industries. The Company operates in two business segments: electronic measurement business and the bio-analytical measurement business. The electronic measurement business provides standard and customized electronic measurement instruments and systems monitoring, management and optimization tools for communications networks and services, software design tools and related services that are used in the design, development, manufacture, installation, deployment and operation of electronics equipment and communications networks and services. The bio-analytical measurement business provides application-focused solutions that include instruments, software, consumables and services that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy